Literature DB >> 7553882

Analysis of the effect of cytokines (interleukins 2, 3, 4, and 6, granulocyte-monocyte colony-stimulating factor, and interferon-gamma) on generation of primary cytotoxic T lymphocytes against a weakly immunogenic tumor.

A J McAdam1, B A Pulaski, E Storozynsky, K Y Yeh, J Z Sickel, J G Frelinger, E M Lord.   

Abstract

We have investigated the role of cytokines (IL-2, IL-3, IL-4, IL-6, IFN-gamma, and GM-CSF) in the generation of primary cytotoxic T lymphocytes (CTL), within a single tumor system. The murine carcinoma line 1 was transfected with expression vectors with cDNA for these cytokines. Line 1 expresses low levels of class I MHC molecules, but can be induced with dimethyl sulfoxide or IFN-gamma to express high levels of class I. Class I low line 1 cells are not susceptible to CTL lysis, while class I high line 1 are lysed by CTL, which allows us to assay for CTL activity. To isolate primary CTL, tumor-infiltrating lymphocytes were isolated from cytokine-expressing or control tumors, growing in vivo. Most cytokines stimulated nonspecific killers, but IL-2 and IL-3 stimulated primary CTL. While IFN-gamma alone did not generate primary CTL, coexpression of IFN-gamma with IL-2 resulted in CTL generation. This is the first comparison of the effects of a series of cytokines on primary CTL development, and has important implications for vaccine development and immunotherapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7553882     DOI: 10.1006/cimm.1995.1204

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  14 in total

1.  Tissue-specific expression of the human prostate-specific antigen gene in transgenic mice: implications for tolerance and immunotherapy.

Authors:  C Wei; R A Willis; B R Tilton; R J Looney; E M Lord; R K Barth; J G Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

2.  Interleukin-3 and granulocyte-macrophage colony-stimulating factor enhance the generation and function of dendritic cells.

Authors:  E Storozynsky; J G Woodward; J G Frelinger; E M Lord
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

3.  GITR agonist enhances vaccination responses in lung cancer.

Authors:  Li X Zhu; Michael Davoodi; Minu K Srivastava; Puja Kachroo; Jay M Lee; Maie St John; Marni Harris-White; Min Huang; Robert M Strieter; Steven Dubinett; Sherven Sharma
Journal:  Oncoimmunology       Date:  2015-04-27       Impact factor: 8.110

4.  Development of an attenuated interleukin-2 fusion protein that can be activated by tumour-expressed proteases.

Authors:  John Puskas; Denise Skrombolas; Abigail Sedlacek; Edith Lord; Mark Sullivan; John Frelinger
Journal:  Immunology       Date:  2011-03-23       Impact factor: 7.397

5.  A BALB/c murine lung alveolar carcinoma used to establish a surgical spontaneous metastasis model.

Authors:  Michael McLean; Howard L Wallace; Atima Sharma; Hank C Hill; Michael S Sabel; Nejat K Egilmez
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

6.  Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex "re-presentation" of exogenous antigen by tumor-infiltrating antigen-presenting cells.

Authors:  B A Pulaski; K Y Yeh; N Shastri; K M Maltby; D P Penney; E M Lord; J G Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

7.  Orchestration of CD4 T cell epitope preferences after multipeptide immunization.

Authors:  Jacqueline Tung; Andrea J Sant
Journal:  J Immunol       Date:  2013-06-14       Impact factor: 5.422

Review 8.  Cancer vaccine development: protein transfer of membrane-anchored cytokines and immunostimulatory molecules.

Authors:  Ashley M Cimino; Purani Palaniswami; Andrew C Kim; Periasamy Selvaraj
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

9.  IL-12 suppresses vascular endothelial growth factor receptor 3 expression on tumor vessels by two distinct IFN-gamma-dependent mechanisms.

Authors:  Elizabeth W Sorensen; Scott A Gerber; John G Frelinger; Edith M Lord
Journal:  J Immunol       Date:  2010-01-08       Impact factor: 5.422

10.  Mechanism of IL-12 mediated alterations in tumour blood vessel morphology: analysis using whole-tissue mounts.

Authors:  S A Gerber; J P Moran; J G Frelinger; J A Frelinger; B M Fenton; E M Lord
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.